← Open Payments lookup

NIRMAL BRAR: Open Payments

NPI 1710982608 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,890 in 111 payments from 14 companies in 2025. Trend: 2023 $1,797 · 2024 $1,232 · 2025 $1,890

Food & beverage: $1,882Education: $8
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.20$414
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)29$318
Supernus Pharmaceuticals, Inc.15$238
Otsuka America Pharmaceutical, Inc.13$221
ABBVIE INC.11$160
Collegium Pharmaceutical, Inc.6$122
Axsome Therapeutics, Inc.4$122
Alkermes, Inc.4$79
E.R. Squibb & Sons, L.L.C.2$57
Tris Pharma Inc2$44

Products named: FANAPT, CAPLYTA, Qelbree, REXULTI, VRAYLAR, Jornay PM, Auvelity, ARISTADA.

Industry payments across CA — which companies pay providers there.